Literature DB >> 29284735

Contact Aspiration Versus Stent Retriever in Patients With Acute Ischemic Stroke With M2 Occlusion in the ASTER Randomized Trial (Contact Aspiration Versus Stent Retriever for Successful Revascularization).

Benjamin Gory1, Bertrand Lapergue2, Raphael Blanc2, Julien Labreuche2, Malek Ben Machaa2, Alain Duhamel2, Gautier Marnat2, Suzana Saleme2, Vincent Costalat2, Serge Bracard2, Hubert Desal2, Mikael Mazighi2, Arturo Consoli2, Michel Piotin2.   

Abstract

BACKGROUND AND
PURPOSE: Middle cerebral artery M2-segment occlusions represent an important subgroup of patients with acute stroke with large-vessel occlusion. The safety of mechanical thrombectomy, especially contact aspiration (CA), in such distal intracranial occlusions is still under debate. We compared reperfusion, adverse events, neurological recovery, and functional outcome of patients with isolated M2 occlusions according to the first-line strategy mechanical thrombectomy devices (CA versus stent retriever [SR]).
METHODS: This is a post hoc analysis of the ASTER trial (Contact Aspiration Versus Stent Retriever for Successful Revascularization). The primary outcome was successful reperfusion at the end of all endovascular procedures, defined as modified Thrombolysis in Cerebral Infarction (mTICI) scores 2b/3. Secondary outcomes were mTICI 2c/3 and mTICI 3, 90-day functional outcome, assessed with the modified Rankin Scale score. Safety outcomes included 90-day mortality and any symptomatic intracerebral hemorrhage.
RESULTS: Seventy-nine patients were included: 48 were allocated to the CA group and 31 to the SR group. There were no significant differences between CA and SR groups in reperfusion after all endovascular procedures regarding mTICI 2b/3 (89.6% versus 83.9%; P=0.36), mTICI 2c/3 (54.2% versus 54.8%; P=0.90), and mTICI 3 (35.4% versus 41.9%; P=0.36) rates. There were no significant differences between CA and SR groups in 90-day modified Rankin Scale ≤2 rate (54.4% versus 50.0%; P=0.84), 24-hour change in National Institutes of Health Stroke Scale (mean difference, -3.9; 95% confidence interval, -7.9 to 0.01), and Alberta Stroke Program Early Computed Tomography score (mean difference, 0.9; 95% confidence interval, -0.1 to 2.0) scores. Safety parameters were well balanced between the 2 groups except for a higher 90-day mortality rate in the CA group (19.6% versus 3.3%; P=0.078).
CONCLUSIONS: First-line mechanical thrombectomy with CA compared with SR did not result in an increased successful revascularization rate in patients with acute stroke with isolated M2 occlusion.
© 2017 American Heart Association, Inc.

Entities:  

Keywords:  aspiration; cerebral hemorrhage; confidence intervals; safety; stent retriever; stroke; thrombectomy

Mesh:

Year:  2017        PMID: 29284735     DOI: 10.1161/STROKEAHA.117.019598

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  13 in total

1.  Mechanical thrombectomy with second-generation devices for acute cerebral middle artery M2 segment occlusion: A meta-analysis.

Authors:  Guangshuo Li; Rui Huang; Weishuai Li; Xiaotian Zhang; Guorong Bi
Journal:  Interv Neuroradiol       Date:  2019-11-05       Impact factor: 1.610

2.  Thrombectomy for M2 occlusions and the role of the dominant branch.

Authors:  Luís Henrique de Castro Afonso; Guilherme Borghini Pazuello; Guilherme Seizem Nakiri; Lucas Moretti Monsignore; Francisco Antunes Dias; Octávio Marques Pontes-Neto; Daniel Giansante Abud
Journal:  Interv Neuroradiol       Date:  2019-05-14       Impact factor: 1.610

3.  Stroke Network of Wisconsin (SNOW) Scale Predicts Large Vessel Occlusion Stroke in the Prehospital Setting.

Authors:  Kessarin Panichpisal; Sarah Erpenbeck; Paul Vilar; Reji P Babygirija; Maharaj Singh; M Riccardo Colella; Richard A Rovin
Journal:  J Patient Cent Res Rev       Date:  2022-04-18

4.  Dose-Response Relationship and Threshold Drug Dosage Identification for a Novel Hybrid Mechanical-Thrombolytic System with an Ultra-Low Dose Patch.

Authors:  Zhen Qin; Chi Hang Chon; John Ching Kwong Kwok; Peter Yat Ming Woo; David C C Lam
Journal:  Cell Mol Bioeng       Date:  2021-06-10       Impact factor: 3.337

Review 5.  Thrombectomy for Acute Ischemic Stroke: Recent Insights and Future Directions.

Authors:  Aravind Ganesh; Mayank Goyal
Journal:  Curr Neurol Neurosci Rep       Date:  2018-07-23       Impact factor: 5.081

6.  Aspiration thrombectomy as the first-line treatment of M2 occlusions.

Authors:  Jan Harsany; Jozef Haring; Matus Hoferica; Miroslav Mako; Pavol Janega; Georgi Krastev; Andrej Klepanec
Journal:  Interv Neuroradiol       Date:  2020-05-12       Impact factor: 1.610

7.  The Aspirations of Direct Aspiration for Thrombectomy in Ischemic Stroke: A Critical Analysis.

Authors:  Tommy Andersson; Martin Wiesmann; Omid Nikoubashman; Anil Gopinathan; Pervinder Bhogal; Leonard L L Yeo
Journal:  J Stroke       Date:  2019-01-31       Impact factor: 6.967

8.  ADAPT technique in ischemic stroke treatment of M2 middle cerebral artery occlusions in comparison to M1 occlusions: Post hoc analysis of the PROMISE study.

Authors:  Pedro Navia; Peter Schramm; Jens Fiehler
Journal:  Interv Neuroradiol       Date:  2019-12-17       Impact factor: 1.610

9.  Benefit of endovascular thrombectomy for M2 middle cerebral artery occlusion in the ARISE II study.

Authors:  Adam de Havenon; Ana Paula Narata; Aymeric Amelot; Jeffrey L Saver; Hormozd Bozorgchami; Heinrich Paul Mattle; Marc Ribo; Tommy Andersson; Osama O Zaidat
Journal:  J Neurointerv Surg       Date:  2020-11-20       Impact factor: 5.836

10.  Microcatheter infusion of bolus-dose tirofiban for acute ischemic stroke due to distal intracranial artery occlusion.

Authors:  Shao Ju Shao; Guo Zhen Zhang; Long Zhao; Fa Rong Huo; Hong Bin Ma; Ling Zhu; Zhi Qi Yang; Rong Yin
Journal:  Medicine (Baltimore)       Date:  2020-07-24       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.